CA2215356C - Novel embolizing compositions - Google Patents
Novel embolizing compositions Download PDFInfo
- Publication number
- CA2215356C CA2215356C CA002215356A CA2215356A CA2215356C CA 2215356 C CA2215356 C CA 2215356C CA 002215356 A CA002215356 A CA 002215356A CA 2215356 A CA2215356 A CA 2215356A CA 2215356 C CA2215356 C CA 2215356C
- Authority
- CA
- Canada
- Prior art keywords
- composition
- weight percent
- biocompatible
- contrast agent
- tantalum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/508,248 US5580568A (en) | 1995-07-27 | 1995-07-27 | Cellulose diacetate compositions for use in embolizing blood vessels |
| US08/508,248 | 1995-07-27 | ||
| US08/507,863 US5667767A (en) | 1995-07-27 | 1995-07-27 | Compositions for use in embolizing blood vessels |
| US08/507,863 | 1995-07-27 | ||
| EP96925568A EP0847240B1 (en) | 1995-07-27 | 1996-07-29 | Novel embolizing compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2215356A1 CA2215356A1 (en) | 1997-02-13 |
| CA2215356C true CA2215356C (en) | 2009-08-25 |
Family
ID=27238028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002215356A Expired - Fee Related CA2215356C (en) | 1995-07-27 | 1996-07-29 | Novel embolizing compositions |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP0847240B1 (enExample) |
| JP (1) | JP4678895B2 (enExample) |
| CN (1) | CN1079642C (enExample) |
| AT (2) | ATE284715T1 (enExample) |
| AU (1) | AU6604396A (enExample) |
| CA (1) | CA2215356C (enExample) |
| DE (2) | DE69626992T2 (enExample) |
| ES (2) | ES2232711T3 (enExample) |
| WO (1) | WO1997004657A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103254A (en) * | 1996-05-31 | 2000-08-15 | Micro Therapeutics, Inc. | Methods for sterilizing male mammals |
| ATE223723T1 (de) * | 1996-05-31 | 2002-09-15 | Micro Therapeutics Inc | Sterilisation weiblicher säugetieren |
| EP0928195B1 (en) | 1996-05-31 | 2003-01-02 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
| US5830178A (en) * | 1996-10-11 | 1998-11-03 | Micro Therapeutics, Inc. | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide |
| AU2814697A (en) * | 1996-07-29 | 1998-02-20 | Micro Therapeutics, Inc. | Novel methods for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide |
| US5785642A (en) * | 1996-10-18 | 1998-07-28 | Micro Therapeutics, Inc. | Methods for treating urinary incontinence in mammals |
| CA2288292A1 (en) * | 1997-04-24 | 1998-10-29 | Nycomed Imaging As | Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| US6569417B2 (en) | 1997-10-10 | 2003-05-27 | Micro Therapeutics, Inc. | Methods for treating urinary incontinence in mammals |
| US6309420B1 (en) | 1997-10-14 | 2001-10-30 | Parallax Medical, Inc. | Enhanced visibility materials for implantation in hard tissue |
| US7572263B2 (en) | 1998-04-01 | 2009-08-11 | Arthrocare Corporation | High pressure applicator |
| AU3203599A (en) | 1998-04-01 | 1999-10-18 | Parallax Medical, Inc. | Pressure applicator for hard tissue implant placement |
| US7132582B2 (en) | 2003-05-30 | 2006-11-07 | Council Of Scientific And Industrial Research | Catalytic process for the preparation of isolongifolene |
| US6251064B1 (en) | 1998-12-11 | 2001-06-26 | Enteric Medical Technologies, Inc. | Method for creating valve-like mechanism in natural body passageway |
| US6238335B1 (en) | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
| US6303100B1 (en) * | 1999-03-19 | 2001-10-16 | Micro Therapeutics, Inc. | Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| AU6168699A (en) | 1999-03-24 | 2000-10-09 | Parallax Medical, Inc. | Non-compliant system for delivery of implant material |
| US6241719B1 (en) * | 1999-05-13 | 2001-06-05 | Micro Therapeutics, Inc. | Method for forming a radioactive stent |
| EP1987847A1 (en) | 1999-05-21 | 2008-11-05 | Micro Therapeutics, Inc. | Novel high viscosity embolizing compositions |
| CA2287112C (en) | 1999-09-02 | 2008-02-19 | Izi Medical Products, Llc | Method and apparatus for strengthening vertebral bodies |
| US6783515B1 (en) | 1999-09-30 | 2004-08-31 | Arthrocare Corporation | High pressure delivery system |
| WO2001068720A1 (en) | 2000-03-13 | 2001-09-20 | Biocure, Inc. | Embolic compositions |
| US7459142B2 (en) | 2002-06-06 | 2008-12-02 | Micro Therapeutics, Inc. | High viscosity embolizing compositions comprising prepolymers |
| US20050065434A1 (en) * | 2003-09-22 | 2005-03-24 | Bavaro Vincent P. | Polymeric marker with high radiopacity for use in medical devices |
| CN100479865C (zh) * | 2003-10-27 | 2009-04-22 | 玛丽亚·赫曼纳斯·吉哈德斯·斯德赫斯 | 空气处理方法和装置 |
| US8048086B2 (en) * | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
| US8360000B2 (en) | 2005-11-28 | 2013-01-29 | Japan Science And Technology Agency | Flocked medical instrument to be placed in the body, method of producing the medical instrument to be placed in the body and apparatus for producing the medical instrument to be placed in the body |
| CN100453125C (zh) * | 2006-11-22 | 2009-01-21 | 山东赛克赛斯药业科技有限公司 | 非粘附性医用液体栓塞剂及其应用 |
| US20100021550A1 (en) * | 2007-01-12 | 2010-01-28 | Yanfang Li | Radiopaque biodegradable vascular embolic microspheres |
| CN102100929B (zh) * | 2010-08-27 | 2013-10-02 | 上海微创医疗器械(集团)有限公司 | 一种栓塞材料及其制备方法 |
| CN102266591A (zh) * | 2011-06-17 | 2011-12-07 | 微创医疗器械(上海)有限公司 | 一种基于胶原蛋白的新型液体栓塞材料及其制备方法 |
| CN102552108B (zh) * | 2012-01-17 | 2014-06-04 | 汤小国 | 一种液体栓塞剂及其制备方法 |
| CN103126973B (zh) * | 2013-02-01 | 2015-02-18 | 安徽四正医药科技有限公司 | 用于血管瘤治疗的多糖水凝胶液体栓塞剂及其制备方法 |
| CA2925606A1 (en) * | 2015-04-23 | 2016-10-23 | Covidien Lp | Resorbable oxidized cellulose embolization solution |
| WO2018137633A1 (zh) * | 2017-01-24 | 2018-08-02 | 珠海神平医疗科技有限公司 | 一种液体栓塞材料及其制备方法 |
| CN107875436B (zh) * | 2017-11-10 | 2020-02-18 | 杭州华微医疗科技有限公司 | 一种负载碳酸氢钠粉末的液体栓塞剂组合物及其应用 |
| CN108785691A (zh) * | 2018-07-06 | 2018-11-13 | 中南大学湘雅二医院 | 一种对微小病灶进行定位检测的人造结节及定位方法 |
| CN110964131B (zh) | 2018-09-29 | 2022-11-22 | 诺维新材有限公司 | 含有多羟基的聚合物及其制备方法和用途 |
| CA3191526A1 (en) * | 2020-09-04 | 2022-03-10 | Suresh S. Pai | Liquid embolic compositions with controlled release of radiopaque and therapeutic compounds and methods of using the same |
| US11801058B2 (en) * | 2021-03-04 | 2023-10-31 | Accumedical Beijing Ltd. | Liquid embolic compositions |
| CN116407667A (zh) * | 2021-12-31 | 2023-07-11 | 神泓医疗科技(上海)有限公司 | 液体栓塞剂及其制备方法和应用 |
| CN116407666A (zh) * | 2021-12-31 | 2023-07-11 | 神泓医疗科技(上海)有限公司 | 液体栓塞剂及其制备方法和应用 |
| CN116370694A (zh) * | 2021-12-31 | 2023-07-04 | 神泓医疗科技(上海)有限公司 | 液体栓塞剂及其制备方法和应用 |
| CN114344551B (zh) * | 2021-12-31 | 2023-06-16 | 神泓医疗科技(上海)有限公司 | 液体栓塞组合物及其应用、医疗介入器械和介入治疗药物 |
| CN116785492B (zh) * | 2022-03-14 | 2026-08-07 | 神泓医疗科技(上海)有限公司 | 液体栓塞剂及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4079124A (en) * | 1976-04-21 | 1978-03-14 | Medi-Physics, Inc. | Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten |
| US4268495A (en) * | 1979-01-08 | 1981-05-19 | Ethicon, Inc. | Injectable embolization and occlusion solution |
| AU3394884A (en) * | 1983-08-31 | 1985-03-29 | S.K.Y. Polymers Inc. | Injectable physiologically acceptable polymeric compositions |
| US4795741A (en) * | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
| ATE130517T1 (de) * | 1990-08-08 | 1995-12-15 | Takeda Chemical Industries Ltd | Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff. |
| JP3040551B2 (ja) * | 1991-09-05 | 2000-05-15 | 株式会社カネカメディックス | 人工塞栓形成用高分子溶液 |
| JP3203382B2 (ja) * | 1992-03-13 | 2001-08-27 | 国立循環器病センター総長 | 人工塞栓形成用高分子溶液 |
| JP2736339B2 (ja) * | 1992-09-30 | 1998-04-02 | 株式会社日本感光色素研究所 | 動脈瘤の液体塞栓材料 |
| US5443454A (en) * | 1992-12-09 | 1995-08-22 | Terumo Kabushiki Kaisha | Catheter for embolectomy |
-
1996
- 1996-07-29 AT AT02075574T patent/ATE284715T1/de active
- 1996-07-29 CA CA002215356A patent/CA2215356C/en not_active Expired - Fee Related
- 1996-07-29 DE DE69626992T patent/DE69626992T2/de not_active Expired - Lifetime
- 1996-07-29 EP EP96925568A patent/EP0847240B1/en not_active Expired - Lifetime
- 1996-07-29 WO PCT/US1996/012436 patent/WO1997004657A1/en not_active Ceased
- 1996-07-29 JP JP50784297A patent/JP4678895B2/ja not_active Expired - Lifetime
- 1996-07-29 ES ES02075574T patent/ES2232711T3/es not_active Expired - Lifetime
- 1996-07-29 AU AU66043/96A patent/AU6604396A/en not_active Abandoned
- 1996-07-29 DE DE69634056T patent/DE69634056T2/de not_active Expired - Lifetime
- 1996-07-29 EP EP02075574A patent/EP1208855B1/en not_active Expired - Lifetime
- 1996-07-29 CN CN96196007A patent/CN1079642C/zh not_active Expired - Fee Related
- 1996-07-29 AT AT96925568T patent/ATE235268T1/de active
- 1996-07-29 ES ES96925568T patent/ES2194110T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69634056T2 (de) | 2005-12-08 |
| EP0847240A4 (en) | 2000-01-19 |
| WO1997004657A1 (en) | 1997-02-13 |
| CA2215356A1 (en) | 1997-02-13 |
| AU6604396A (en) | 1997-02-26 |
| EP1208855B1 (en) | 2004-12-15 |
| CN1192654A (zh) | 1998-09-09 |
| JP2000505045A (ja) | 2000-04-25 |
| EP1208855A1 (en) | 2002-05-29 |
| DE69626992T2 (de) | 2003-12-18 |
| ES2194110T3 (es) | 2003-11-16 |
| DE69626992D1 (de) | 2003-04-30 |
| EP0847240A1 (en) | 1998-06-17 |
| ATE284715T1 (de) | 2005-01-15 |
| ATE235268T1 (de) | 2003-04-15 |
| CN1079642C (zh) | 2002-02-27 |
| EP0847240B1 (en) | 2003-03-26 |
| DE69634056D1 (de) | 2005-01-20 |
| JP4678895B2 (ja) | 2011-04-27 |
| ES2232711T3 (es) | 2005-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5695480A (en) | Embolizing compositions | |
| EP1208855B1 (en) | Embolizing compositions | |
| EP0841854B1 (en) | Compositions for embolizing blood vessels | |
| CA2371321C (en) | Novel high viscosity embolizing compositions | |
| US6756031B2 (en) | Compositions for use in embolizing blood vessels | |
| US5830178A (en) | Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide | |
| EP0843560B1 (en) | Cellulose diacetate compositions for use in embolizing blood vessels | |
| US6051607A (en) | Vascular embolizing compositions comprising ethyl lactate and methods for their use | |
| EP2374484A2 (en) | Methods for embolizing blood vessels | |
| EP0923399B1 (en) | Kit of parts comprising three vials for embolizing vascular sites with an embolizing composition comprising dimethylsulfoxide | |
| JP5183157B2 (ja) | 新規な塞栓形成組成物 | |
| CA2244418C (en) | Methods for embolizing blood vessels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150729 |